News

On 12-16 April 2021, the 64th session of the Commission on Narcotic Drugs takes place in Vienna. Head of Lithuanian delegation, Minister of Health, Mr. Arunas Dulkys delivered a national statement.

He stressed that within the framework of international treaties and taking the UNGASS outcome document as a roadmap, Lithuania has developed a comprehensive and horizontal policy that encompasses drugs, alcohol, and tobacco use disorders. Lithuanian National Strategy launched in 2018, promotes a health-based approach to the use of psychoactive substances and provides a commitment to help people protect or recover their health, well-being and the quality of life.

In line with the UNGASS outcome document and the prevention quality standards, Lithuania is developing an evidence-based prevention that focuses on the contextual, environmental, and varied needs of target groups. An early intervention programme with a special attention to vulnerable groups is applied nationally.  Implementation of a take-home naloxone programme resulted in decrease of drug-related deaths by 55 % since 2015. Legal barriers to access cannabis-based medicines were eliminated. We developed pro-active monitoring tools for drug precursors and designer precursors. Our generic approach and decisions on rapid response to NPS threats resulted in a low level of its supply and demand.

Despite the progress made, significant challenges are lying ahead, especially in view of the COVID-19 situation. We are determined to work together with all Member States and other relevant stakeholders respectfully and openly to ensure a better and dignified life for all. Lithuania has recently applied for a CND membership for the term 2022-2025 and would very much appreciate kind support of ECOSOC members  in the upcoming elections.

Full statement by Lithuania's Health Minister can be found here.